OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
GLP-1 Agonist to Treat Obesity and Prevent Cardiovascular Disease: What Have We Achieved so Far?
Maurício Reis Pedrosa, Denise Reis Franco, Hannah Waisberg Gieremek, et al.
Current Atherosclerosis Reports (2022) Vol. 24, Iss. 11, pp. 867-884
Closed Access | Times Cited: 47
Maurício Reis Pedrosa, Denise Reis Franco, Hannah Waisberg Gieremek, et al.
Current Atherosclerosis Reports (2022) Vol. 24, Iss. 11, pp. 867-884
Closed Access | Times Cited: 47
Showing 1-25 of 47 citing articles:
GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach
Jingyue Wang, Quanwei Wang, Xinyu Yang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 120
Jingyue Wang, Quanwei Wang, Xinyu Yang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 120
Perioperative management of long-acting glucagon-like peptide-1 (GLP-1) receptor agonists: concerns for delayed gastric emptying and pulmonary aspiration
Mark L. van Zuylen, Sarah E. Siegelaar, Mark P. Plummer, et al.
British Journal of Anaesthesia (2024) Vol. 132, Iss. 4, pp. 644-648
Closed Access | Times Cited: 37
Mark L. van Zuylen, Sarah E. Siegelaar, Mark P. Plummer, et al.
British Journal of Anaesthesia (2024) Vol. 132, Iss. 4, pp. 644-648
Closed Access | Times Cited: 37
New advances in type 1 diabetes
Savitha Subramanian, Farah Khan, Irl B. Hirsch
BMJ (2024), pp. e075681-e075681
Open Access | Times Cited: 23
Savitha Subramanian, Farah Khan, Irl B. Hirsch
BMJ (2024), pp. e075681-e075681
Open Access | Times Cited: 23
Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism
Tong Bu, Ziyan Sun, Yi Pan, et al.
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 3, pp. 354-372
Open Access | Times Cited: 21
Tong Bu, Ziyan Sun, Yi Pan, et al.
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 3, pp. 354-372
Open Access | Times Cited: 21
Medical therapy to treat obesity and optimize fertility in women of reproductive age: a narrative review
Janelle Duah, David B. Seifer
Reproductive Biology and Endocrinology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Janelle Duah, David B. Seifer
Reproductive Biology and Endocrinology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023
Harold Bays, Shagun Bindlish, Tiffany Lowe Clayton
Obesity Pillars (2023) Vol. 5, pp. 100056-100056
Open Access | Times Cited: 32
Harold Bays, Shagun Bindlish, Tiffany Lowe Clayton
Obesity Pillars (2023) Vol. 5, pp. 100056-100056
Open Access | Times Cited: 32
Very low-calorie ketogenic diet (VLCKD): an antihypertensive nutritional approach
Luigi Barrea, Ludovica Verde, Pasquale Santangeli, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 22
Luigi Barrea, Ludovica Verde, Pasquale Santangeli, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 22
Bariatric Metabolic Surgery vs Glucagon-Like Peptide-1 Receptor Agonists and Mortality
Dror Dicker, Yael Wolff Sagy, Noga Ramot, et al.
JAMA Network Open (2024) Vol. 7, Iss. 6, pp. e2415392-e2415392
Open Access | Times Cited: 13
Dror Dicker, Yael Wolff Sagy, Noga Ramot, et al.
JAMA Network Open (2024) Vol. 7, Iss. 6, pp. e2415392-e2415392
Open Access | Times Cited: 13
The Body weight Reducing Effects of Tirzepatide in People with and without Type 2 Diabetes: A Review on Efficacy and Adverse Effects
Thomas Leth Jensen, Andreas Brønden, Kristian Karstoft, et al.
Patient Preference and Adherence (2024) Vol. Volume 18, pp. 373-382
Open Access | Times Cited: 11
Thomas Leth Jensen, Andreas Brønden, Kristian Karstoft, et al.
Patient Preference and Adherence (2024) Vol. Volume 18, pp. 373-382
Open Access | Times Cited: 11
The Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists for Insufficient Weight Loss or Regain After Metabolic/Bariatric Surgery: A Systematic Review and Meta-analysis
Joanne Kellett, Sara Soliman, Alicia Podwójniak, et al.
Obesity Surgery (2025)
Closed Access | Times Cited: 1
Joanne Kellett, Sara Soliman, Alicia Podwójniak, et al.
Obesity Surgery (2025)
Closed Access | Times Cited: 1
Obesity, cardiovascular and cerebrovascular disease: the role of GLP-1 receptor agonists
Amedeo Tirandi, Fabrizio Montecucco, Federico Carbone, et al.
Polskie Archiwum Medycyny Wewnętrznej (2024)
Open Access | Times Cited: 5
Amedeo Tirandi, Fabrizio Montecucco, Federico Carbone, et al.
Polskie Archiwum Medycyny Wewnętrznej (2024)
Open Access | Times Cited: 5
Risiko für schwere kardiovaskuläre Ereignisse und Schlaganfall gesenkt
Hans‐Christoph Diener
InFo Neurologie + Psychiatrie (2025) Vol. 27, Iss. 1, pp. 14-14
Closed Access
Hans‐Christoph Diener
InFo Neurologie + Psychiatrie (2025) Vol. 27, Iss. 1, pp. 14-14
Closed Access
Semaglutide in Obesity and Type 2 Diabetes Management: A Systematic Review of Clinical Outcomes
Sri Ram Charan Gundapaneni, Rithwik Goud Burri, Reigetsu Kaku, et al.
Cureus (2025)
Open Access
Sri Ram Charan Gundapaneni, Rithwik Goud Burri, Reigetsu Kaku, et al.
Cureus (2025)
Open Access
Effects of Anti-Diabetic Drugs on Erectile Dysfunction: A Systematic Review and Meta-Analysis
Bo Yang, Hui-Yun Cheng, Yu‐Feng Hu, et al.
Diabetes Metabolic Syndrome and Obesity (2025) Vol. Volume 18, pp. 467-478
Open Access
Bo Yang, Hui-Yun Cheng, Yu‐Feng Hu, et al.
Diabetes Metabolic Syndrome and Obesity (2025) Vol. Volume 18, pp. 467-478
Open Access
Semaglutide as a GLP-1 Agonist: A Breakthrough in Obesity Treatment
Richard Salvador, Carla Moutinho, Carla Silva, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 399-399
Open Access
Richard Salvador, Carla Moutinho, Carla Silva, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 399-399
Open Access
Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss
Allison B. Reiss, Shelly Gulkarov, Raymond Lau, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 408-408
Open Access
Allison B. Reiss, Shelly Gulkarov, Raymond Lau, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 408-408
Open Access
Use of probiotics in preventing and treating excess weight and obesity. A systematic review
Belén Torres, María C. Sánchez, Leire Virto, et al.
Obesity Science & Practice (2024) Vol. 10, Iss. 3
Open Access | Times Cited: 4
Belén Torres, María C. Sánchez, Leire Virto, et al.
Obesity Science & Practice (2024) Vol. 10, Iss. 3
Open Access | Times Cited: 4
Use of the FreeStyle Libre system and diabetes treatment progression in T2DM : Results from a retrospective cohort study using a Canadian private payer claims database
Stewart B. Harris, Fleur Levrat‐Guillen
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 6, pp. 1704-1713
Open Access | Times Cited: 9
Stewart B. Harris, Fleur Levrat‐Guillen
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 6, pp. 1704-1713
Open Access | Times Cited: 9
Glucagon-like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth
Casey Berman, Alaina P. Vidmar, Lily C. Chao
touchREVIEWS in Endocrinology (2023) Vol. 19, Iss. 1, pp. 38-38
Open Access | Times Cited: 9
Casey Berman, Alaina P. Vidmar, Lily C. Chao
touchREVIEWS in Endocrinology (2023) Vol. 19, Iss. 1, pp. 38-38
Open Access | Times Cited: 9
Efficacy and safety of glucagon-like peptide-1 receptor agonists on prediabetes: a systematic review and meta-analysis of randomized controlled trials
Hazem Mohamed Salamah, Ahmed Marey, Mohamed Abugdida, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Hazem Mohamed Salamah, Ahmed Marey, Mohamed Abugdida, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Incretin‐based therapies for the management of cardiometabolic disease in the clinic: Past, present, and future
James P. Psaltis, Jessica A. Marathe, Mau T. Nguyen, et al.
Medicinal Research Reviews (2024) Vol. 45, Iss. 1, pp. 29-65
Open Access | Times Cited: 3
James P. Psaltis, Jessica A. Marathe, Mau T. Nguyen, et al.
Medicinal Research Reviews (2024) Vol. 45, Iss. 1, pp. 29-65
Open Access | Times Cited: 3
Bariatric and metabolic surgery in patients with low body mass index: an online survey of 543 bariatric and metabolic surgeons
Shahab Shahabi Shahmiri, Chetan Parmar, Wah Yang, et al.
BMC Surgery (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Shahab Shahabi Shahmiri, Chetan Parmar, Wah Yang, et al.
BMC Surgery (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Glucagon-Like Peptide 1 Therapy: From Discovery to Type 2 Diabetes and Beyond
Adie Viljoen, Stephen C. Bain
Endocrinology and Metabolism (2023) Vol. 38, Iss. 1, pp. 25-33
Open Access | Times Cited: 7
Adie Viljoen, Stephen C. Bain
Endocrinology and Metabolism (2023) Vol. 38, Iss. 1, pp. 25-33
Open Access | Times Cited: 7
Molecular Processes Involved in the Shared Pathways between Cardiovascular Diseases and Diabetes
Julita Tokarek, Emilian Budny, Maciej Saar, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2611-2611
Open Access | Times Cited: 6
Julita Tokarek, Emilian Budny, Maciej Saar, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2611-2611
Open Access | Times Cited: 6
New Insights into Cardiovascular Diseases Treatment Based on Molecular Targets
Armanda Wojtasińska, Joanna Kućmierz, Julita Tokarek, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16735-16735
Open Access | Times Cited: 5
Armanda Wojtasińska, Joanna Kućmierz, Julita Tokarek, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16735-16735
Open Access | Times Cited: 5
